Biotherapeutics Scientist | Driving Innovation from Lab to Clinic With an MSc in Biotherapeutics and hands-on experience in antibody discovery, QC analytics, and regulatory compliance, I bridge the gap between R&D and commercial biomanufacturing. My focus: Therapeutic Development: Designed phage display/ELISA assays to identify antibody mimetics for oncology targets (e.g., CD20). Quality & Compliance: Executed ICH/FDA-aligned method validations (HPLC, FPLC) and reduced QC turnaround time by 40% at Conway Institute. Translational Impact: Contributed to CMC documentation for vaccine submissions, ensuring smooth regulatory transitions. Passionate about advancing next-gen biologics (ADCs, CAR-T) through robust science and efficient processes. 🔍 Open to: Scientist roles in Biopharma R&D, Process Development, or QC/QA.